The ambiguous role of C/EBPδ in pancreatic cancer

L. Hartl

The ambiguous role of C/EBPδ in pancreatic cancer

Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Abstract

Pancreatic Ductal Adenocarcinoma (PDAC) is a highly lethal cancer with an increasing incidence and a devastatingly low 5-year survival rate. It is often diagnosed at a late stage when the primary tumor has spread to distant organs, leaving these patients with insufficient treatment options. To improve these poor prognoses, we must enhance our understanding of the molecular biolog

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	University of Amsterdam
Supervisors/Advisors	Bijlsma, Maarten, Supervisor Medema, Jan Paul, Supervisor Duitman, Jan Willem, Co-supervisor Spek, Christoffel, Co-supervisor
Award date	17 Nov 2023
Publication status	Published - 2023

Access to Document

Cite this

@phdthesis{a8364f533ab8497ab2d6f0e92251d50a,

title = "The ambiguous role of C/EBPδ in pancreatic cancer",

abstract = "Pancreatic Ductal Adenocarcinoma (PDAC) is a highly lethal cancer with an increasing incidence and a devastatingly low 5-year survival rate. It is often diagnosed at a late stage when the primary tumor has spread to distant organs, leaving these patients with insufficient treatment options. To improve these poor prognoses, we must enhance our understanding of the molecular biolog",

author = "L. Hartl",

year = "2023",

language = "English",

type = "Phd-Thesis - Research and graduation internal",

school = "University of Amsterdam",

}

TY - THES

T1 - The ambiguous role of C/EBPδ in pancreatic cancer

AU - Hartl, L.

PY - 2023

Y1 - 2023

N2 - Pancreatic Ductal Adenocarcinoma (PDAC) is a highly lethal cancer with an increasing incidence and a devastatingly low 5-year survival rate. It is often diagnosed at a late stage when the primary tumor has spread to distant organs, leaving these patients with insufficient treatment options. To improve these poor prognoses, we must enhance our understanding of the molecular biolog

AB - Pancreatic Ductal Adenocarcinoma (PDAC) is a highly lethal cancer with an increasing incidence and a devastatingly low 5-year survival rate. It is often diagnosed at a late stage when the primary tumor has spread to distant organs, leaving these patients with insufficient treatment options. To improve these poor prognoses, we must enhance our understanding of the molecular biolog

UR - https://pure.uva.nl/ws/files/144609975/Licence_Agreement_co-signed_.pdf

M3 - Phd-Thesis - Research and graduation internal

ER -

The ambiguous role of C/EBPδ in pancreatic cancer

Abstract

Access to Document

Other files and links

Cite this